Laporan Laba Rugi (TTM)
Laporan Laba Rugi Sumitomo Pharma Co., Ltd. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 513,627 | 520,477 | 515,952 | 513,291 | 548,184 | 553,262 | 560,035 | 588,715 | 585,594 | 588,228 | 555,544 | 471,354 | 388,897 | 330,307 | 314,558 | 329,547 | 342,665 | 372,713 | 398,832 | 416,159 |
Change (%) | 1.33 | -0.87 | -0.52 | 6.80 | 0.93 | 1.22 | 5.12 | -0.53 | 0.45 | -5.56 | -15.15 | -17.49 | -15.07 | -4.77 | 4.77 | 3.98 | 8.77 | 7.01 | 4.34 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 144,081 | 141,126 | 137,773 | 140,279 | 143,805 | 150,813 | 157,127 | 164,707 | 173,114 | 179,058 | 178,919 | 163,293 | 146,401 | 132,343 | 126,577 | 131,096 | 138,581 | 147,153 | 153,437 | 162,600 |
Change (%) | -2.05 | -2.38 | 1.82 | 2.51 | 4.87 | 4.19 | 4.82 | 5.10 | 3.43 | -0.08 | -8.73 | -10.34 | -9.60 | -4.36 | 3.57 | 5.71 | 6.19 | 4.27 | 5.97 | |
% of Revenue | 28.05 | 27.11 | 26.70 | 27.33 | 26.23 | 27.26 | 28.06 | 27.98 | 29.56 | 30.44 | 32.21 | 34.64 | 37.65 | 40.07 | 40.24 | 39.78 | 40.44 | 39.48 | 38.47 | 39.07 |
Gross Operating Profit | 369,546 | 379,351 | 378,179 | 373,012 | 404,379 | 402,449 | 402,908 | 424,008 | 412,480 | 409,170 | 376,625 | 308,061 | 242,496 | 197,964 | 187,981 | 198,451 | 204,084 | 225,560 | 245,395 | 253,559 |
Change (%) | 2.65 | -0.31 | -1.37 | 8.41 | -0.48 | 0.11 | 5.24 | -2.72 | -0.80 | -7.95 | -18.20 | -21.28 | -18.36 | -5.04 | 5.57 | 2.84 | 10.52 | 8.79 | 3.33 | |
% of Revenue | 71.95 | 72.89 | 73.30 | 72.67 | 73.77 | 72.74 | 71.94 | 72.02 | 70.44 | 69.56 | 67.79 | 65.36 | 62.35 | 59.93 | 59.76 | 60.22 | 59.56 | 60.52 | 61.53 | 60.93 |
SG&A | 190,219 | 192,295 | 173,666 | 186,715 | 220,722 | 215,676 | 217,339 | 232,567 | 277,888 | 317,779 | 339,212 | 336,814 | 319,776 | 241,301 | 429,538 | 400,005 | 353,657 | 369,020 | 160,386 | 170,904 |
Change (%) | 1.09 | -9.69 | 7.51 | 18.21 | -2.29 | 0.77 | 7.01 | 19.49 | 14.36 | 6.74 | -0.71 | -5.06 | -24.54 | 78.01 | -6.88 | -11.59 | 4.34 | -56.54 | 6.56 | |
% of Revenue | 37.03 | 36.95 | 33.66 | 36.38 | 40.26 | 38.98 | 38.81 | 39.50 | 47.45 | 54.02 | 61.06 | 71.46 | 82.23 | 73.05 | 136.55 | 121.38 | 103.21 | 99.01 | 40.21 | 41.07 |
R&D | 104,167 | 103,086 | 132,682 | 129,367 | 93,741 | 128,794 | 94,903 | 96,896 | 99,177 | 103,117 | 131,858 | 135,280 | 132,234 | 129,509 | 112,637 | 97,917 | 88,553 | 75,729 | 49,865 | 44,916 |
Change (%) | -1.04 | 28.71 | -2.50 | -27.54 | 37.39 | -26.31 | 2.10 | 2.35 | 3.97 | 27.87 | 2.60 | -2.25 | -2.06 | -13.03 | -13.07 | -9.56 | -14.48 | -34.15 | -9.92 | |
% of Revenue | 20.28 | 19.81 | 25.72 | 25.20 | 17.10 | 23.28 | 16.95 | 16.46 | 16.94 | 17.53 | 23.73 | 28.70 | 34.00 | 39.21 | 35.81 | 29.71 | 25.84 | 20.32 | 12.50 | 10.79 |
OpEx | 450,001 | 431,480 | 461,653 | 473,957 | 457,932 | 528,271 | 500,068 | 522,440 | 547,414 | 604,266 | 681,893 | 663,884 | 627,262 | 556,624 | 669,694 | 636,221 | 619,482 | 596,878 | 385,809 | 379,004 |
Change (%) | -4.12 | 6.99 | 2.67 | -3.38 | 15.36 | -5.34 | 4.47 | 4.78 | 10.39 | 12.85 | -2.64 | -5.52 | -11.26 | 20.31 | -5.00 | -2.63 | -3.65 | -35.36 | -1.76 | |
% of Revenue | 87.61 | 82.90 | 89.48 | 92.34 | 83.54 | 95.48 | 89.29 | 88.74 | 93.48 | 102.73 | 122.74 | 140.85 | 161.29 | 168.52 | 212.90 | 193.06 | 180.78 | 160.14 | 96.73 | 91.07 |
Operating Income | 63,626 | 88,997 | 54,299 | 39,334 | 90,252 | 24,991 | 59,967 | 66,275 | 38,180 | -16,038 | -126,349 | -192,530 | -238,365 | -226,317 | -355,136 | -306,674 | -276,817 | -224,165 | 13,023 | 37,155 |
Change (%) | 39.88 | -38.99 | -27.56 | 129.45 | -72.31 | 139.95 | 10.52 | -42.39 | -142.01 | 687.81 | 52.38 | 23.81 | -5.05 | 56.92 | -13.65 | -9.74 | -19.02 | -105.81 | 185.30 | |
% of Revenue | 12.39 | 17.10 | 10.52 | 7.66 | 16.46 | 4.52 | 10.71 | 11.26 | 6.52 | -2.73 | -22.74 | -40.85 | -61.29 | -68.52 | -112.90 | -93.06 | -80.78 | -60.14 | 3.27 | 8.93 |
Interest Expense | -289 | -9,270 | -2,436 | -1,459 | -2,970 | -2,893 | -3,289 | -3,361 | -2,640 | -8,635 | -16,732 | -4,569 | -4,277 | -5,502 | -55,652 | -7,592 | -6,221 | -39,969 | ||
Change (%) | 3,107.61 | -73.72 | -40.11 | -2.59 | 13.69 | 2.19 | -21.45 | 227.08 | 93.77 | -72.69 | -6.39 | 28.64 | 911.49 | -86.36 | -18.06 | 542.49 | ||||
% of Revenue | -0.06 | -1.78 | -0.47 | -0.28 | -0.53 | -0.49 | -0.56 | -0.57 | -0.48 | -1.83 | -4.30 | -1.38 | -1.36 | -1.67 | -16.24 | -2.04 | -1.56 | -9.60 | ||
Net Income | 47,720 | 67,031 | 56,219 | 42,762 | 55,372 | 32,321 | 56,413 | 82,719 | 12,680 | -8,448 | -74,512 | -144,485 | -134,970 | -173,718 | -314,969 | -260,167 | -279,457 | -176,042 | 23,634 | 18,903 |
Change (%) | 40.47 | -16.13 | -23.94 | 29.49 | -41.63 | 74.54 | 46.63 | -84.67 | -166.62 | 782.01 | 93.91 | -6.59 | 28.71 | 81.31 | -17.40 | 7.41 | -37.01 | -113.43 | -20.02 | |
% of Revenue | 9.29 | 12.88 | 10.90 | 8.33 | 10.10 | 5.84 | 10.07 | 14.05 | 2.17 | -1.44 | -13.41 | -30.65 | -34.71 | -52.59 | -100.13 | -78.95 | -81.55 | -47.23 | 5.93 | 4.54 |
Source: Capital IQ